Navigation Links
WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
Date:3/24/2009

yond the control of the company. Actual results may differ materially from the expectations contained in the forward-looking statements. Factors that may cause such differences include the risks that: (i) each company may be unsuccessful in achieving the anticipated results of research and/or in commercially developing its products or in achieving market acceptance of new and relatively unproven technologies; (ii) each company will need to raise additional capital to meet its business requirements in the future and the company may not be able to do so on reasonable terms or at all; (iii) each company's proprietary intellectual property rights may not adequately protect its products and technologies; and (iv) each company expects intense competition in its target markets, including from companies that have much greater resources than the company, and there can be no assurance that the company will be able to compete effectively. More detailed information about the company and the risk factors that may affect the realization of forward-looking statements is set forth in each company's filings with the Securities and Exchange Commission, including each company's Annual Report on Form 10-K for the year ended December 31, 2007, and its subsequent Quarterly Reports on Form 10-Q filed with the SEC. Investors and security holders are urged to read this document free of charge on the SEC's web site at www.sec.gov. Each company does not undertake to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

    Contact:

    Vida Communication (Media)                The Trout Group (Investors)
    On Behalf of WaferGen                     On Behalf of WaferGen
    Tim Brons                                 Peter Rahmer
    415-675-7400                              646-378-2973
    tbrons@vidacommu
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
2. Data on WaferGens SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference
3. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
4. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
5. WaferGen Announces Third Quarter 2008 Financial Results
6. WaferGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
7. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
8. WaferGen to Present at the Seventh Annual BIO Investor Forum
9. WaferGen Announces Second Quarter 2008 Financial Results
10. WaferGen to Present at the Ninth Annual Beyond Genome Conference
11. WaferGen Announces Signing of Two Private Placements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... and HONG KONG , ... rare disease therapeutics enterprise, announced today that rare disease ... company as vice president, research. Dr. McKew brings more ... key leadership positions at the National Institutes of Health, ... acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts to ...
(Date:10/20/2014)... GUELPH, ON , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. ... totalling $1.7 million which brings Q3 orders to $5.8 million and ... odour control projects in North America and ... "We continue to bid new projects at record levels," said ... values were higher at the end of Q3 than they have ...
(Date:10/20/2014)... October 20, 2014 Earle ... LLC, announced today that Ellen Teplitzky, an experienced ... for the pharmaceutical industry, has joined the firm ... its legal services practice. NDA Partners provides ... witness and testimony, to top law firms and ...
(Date:10/19/2014)... The Asia-Pacific Bromine Market report defines ... analysis and forecast of revenue. , Browse through ... report, to get an idea of the in-depth ... the segmentation in the Asia-Pacific bromine market, and ... , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine is a ...
Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... , CALGARY and BLENHEIM, Ontario, Nov. 24 Dow AgroSciences ... Seeds, a division of Thompsons Limited of Blenheim, Ontario. The ... seeds business as the company anticipates the introduction of ... AgroSciences Herbicide Tolerant Trait Technology in corn in 2012. The ...
... , SHANGHAI, Nov. 24 ... Trademark Office (PTO) has allowed the patent application for,its ... NOD technology is a highly efficient approach ... oral delivery of drugs,otherwise administered as injections. NOD technology ...
... , , Primary efficacy endpoint has ... recurrent endometrial cancer, , QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - ... "Company"), a global biopharmaceutical company focused on endocrine therapy and ... study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), ...
Cached Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
(Date:10/18/2014)... October 2014 Psychological stress and stress-related psychiatric disorders ... diseases, but the molecular mechanisms underlying this ... contribute to the development of targeted preventive ... these devastating diseases. This work is presented ... in Berlin., Now an international group of ...
(Date:10/17/2014)... the University of Copenhagen have shown for the first ... of Cystic fibrosis patients, giving them the opportunity to ... chronic infections. , The study also discovered the bacterial ... patients was halted or slowed down by the immune ... the oxygen and helped "suffocate" the bacteria, forcing the ...
(Date:10/16/2014)... on how the bowel lining develops and, in the ... starts. , The researchers produced evidence that stem cells ... are a feature of the bowel lining, and believe ... a controversial finding as scientists are still divided on ... Dr Chin Wee Tan and Professor Tony Burgess from ...
Breaking Biology News(10 mins):Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2
... Today sees the launch of Ensembl Plants ... research by the European Molecular Biology Laboratory,s ... Cold Spring Harbor Laboratory, USA. Ensembl Plants allows ... of genome-scale experiments in different plant species. By ...
... good, more must be better, right? Wrong! New research published ... shows that vitamin A plays a crucial role in energy ... has a complex negative effect on our bodies. This is ... supplements containing added vitamin A make an overdose more possible ...
... calorie intake or glance over nutritional information on food packages, ... Dr. Susan Nelson, a veterinarian and assistant professor of clinical ... to follow when feeding your pet to ensure that it ... cat and dog food packages contain nutritional information, Nelson said. ...
Cached Biology News:New portal for plant genomics will support research into improved crops 2Too much of a good thing? Scientists explain cellular effects of vitamin A overdose and deficiency 2Owners should count calories for obese pets, consider several factors for good health 2Owners should count calories for obese pets, consider several factors for good health 3
... I, Wild Type Liquid. In 100 ... 200 µM EDTA, 20% glycerol, pH 7.9. AVOID ... is a monomeric protein of 765 amino acids ... relaxation of both positive and negative supercoiled DNAs ...
Request Info...
... in a 3'-> 5' direction from a ... of single-stranded DNA. Under defined reaction conditions, ... a uniform rate yielding predictable and reproducible ... of deoxyribonucleotides by Exonuclease III is dependent ...
... an endoribonuclease, the RNA strand of ... origin, e.g. that of phage FX174, ... x poly(dT). RNase H produces ribonucleotides ... no activity is detected with polyribonucleotides ...
Biology Products: